Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS other · 2026-03-24

Clinical Trial Update: PerQdisc Traditional Feasibility Trial. [NA]

View source ↗

Summary

The PerQdisc Traditional Feasibility Trial for discogenic back pain is currently recruiting, sponsored by Spinal Stabilization Technologies.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • PerQdisc Traditional

Snippet

Sponsor: Spinal Stabilization Technologies | Conditions: Discogenic Low Back Pain | NA | Status: RECRUITING